Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

flutemetamol F 18

A radiopharmaceutical containing flutemetamol, a thioflavin derivative of Pittsburgh compound B (PiB) labeled with the radioisotope fluorine F18 that can be used to detect beta-amyloid deposition upon positron emission tomography (PET). After intravenous administration of flutemetamol F 18, the flutemetamol moiety selectively accumulates in and binds to cerebral fibrillar amyloid-beta in the brain. The fluorine F18 radioisotope moiety is detected using PET, which allows imaging and quantification of amyloid-beta density. Amyloid plaque deposition is linked to cognitive decline, including Alzheimer’s disease, and may be linked to chemotherapy-induced cognitive impairment (CICI).
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:[18F]flutemetamol
[18F]FPIB
[18F]GE-067
fluorine F 18 flutemetamol
flutemetamol F-18
US brand name:Vizamyl
Chemical structure:2-[3-(18F)fluoro-4-(methylamino)phenyl]-1,3-benzothiazol-6-ol
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search